baber/WOPTO huggingface dataset:
Patent PT-597817-E (PT)
Inventor: FALKVALL THORE
IPC: G06Q50/22
Filed: 1993-11-12
Abstract: Improvements relating to methods and apparatuses for kidney dialysis are disclosed. These include checking of dialysate bypass status using flow measurement; using a flow sensor to confirm the absence of ultrafiltration during bypass; automatic testing of ultrafiltration function by removal of a discrete volume from a portion of the dialysate flow path coupled with a pressure test of that part of the flow path; using a touch screen user interface; bar graph profile programming of ultrafiltration, sodium, and bicarbonate parameters; using a RAM card to upload treatment instructions to, and to download treatment data from, the machine; automatic setting of proportioning mode (acetate or bicarbonate) based on connections of concentrate lines; predicting dialysate conductivity values based on brand and formulation of concentrates; minimizing no-flow dead time between dialysate pulses; initiating operation in a timed mode from a machine power-off condition; preserving machine mode during machine power-fail condition; calibration scheduling and reminding; automatic level adjusting; and blood leak flow rate detecting. The UF profiling feature allows shifting of a proposed profile along a UF-rate axis to ensure the volume of ultrafiltrate to be removed from a patient equals a target UF volume. This feature also allows programming of the UF profile to automatically conform to the sodium profile and saving of a particular UF profile for later recall. <IMAGE>
Patent PT-771839-E (PT)
Inventor: SCHWENK GERHARD
IPC: C08G18/38
Filed: 1996-10-31
Abstract: Pigment composition (I), comprising (a) a dye fixed in (b) a solid resin consisting of the reaction product of (b1) an oligomerised polyisocyanate and (b2) a mixture of polyfunctional compounds with active hydrogen. Also claimed is (i) a process for the production of (I), by mixing (a) with (b1) and (b2), reacting at elevated temperature to form a solid resin, and milling the resin to the required particle size; (ii) a data storage medium containing composition (I), especially a security document or a consumer product, on which composition (I) is printed in the form of a code.
Patent PT-871757-E (PT)
Inventor: DROPULIC BORO
IPC: C12N15/867
Filed: 1996-11-27
Abstract: The present invention provides a conditionally replicating viral vector, methods of making, modifying, propagating and selectively packaging, and using such a vector, isolatd molecules of specified nucleotide and amino acid sequences relevant to such vectors, a pharmaceutical composition and a host cell comprising such a vector, the use of such a host cell to screen drugs. The methods include the prophylactic and therapeutic treatment of viral infection, in particular HIV infection, and, thus, are also directed to viral vaccines and the treatment of cancer, in particular cancer of viral etiology. Other methods include the use of such conditionally replicating viral vectors in gene therapy and other applications. <IMAGE> <IMAGE> <IMAGE> <IMAGE> <IMAGE>
Patent PT-838214-E (PT)
Inventor: WESTENFELDER HORST
IPC: A61Q1/00
Filed: 1997-10-10
Abstract: A topical cosmetic for protecting the skin or hair against UV contains (a) a 2,4,6-tris-amino-s-triazine derivative A, B or C of formula (I) as a first UV filter; and (b) at least one further UV filter (II) selected from ethyl p-aminobenzoate (25 mol) ethoxylated, 2-ethylhexyl p-methoxycinnamate, 2-ethylhexyl-2-cyano-3,3-diphenyl-acrylate, 2-phenylbenzimidazole-5-sulphonic acid (or its salt), 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxybenzophenone-5-sulphonic acid, 3-(4'-methylbenzylidene)-d,l-camphor or 2,4,6-trianilino-(p-carbo-2'-ethylhexyl-1'-hydroxy)-1,3,5-triazine. In A, R1 = 2-ethylhexyl, R2 = tert. butyl and X = NH; in B, R1, R2 = 2-isopropyl-5-methyl-cyclohexyl and X = O; and in C, R1 = methylcyclohexyl, R2 = 2-ethylhexyl and X = O. Also claimed is the use of combinations of (I) and (II) as a light protectant.
Patent PT-938661-E (PT)
Inventor: PERKINS ELAINE ANN
IPC: G01N21/55
Filed: 1997-11-05
Abstract: A surface plasmon resonance apparatus for detecting a soluble analyte (e.g. a protein) or a particulate analyte (e.g. a cell), the apparatus comprising: (a) a sensor block adapted to receive a sensor, said sensor, for example a sensor slide, having a metallised sensor surface capable of binding the analyte; (b) a light source capable of generating an evanescent wave at the sensor surface of a sensor slide on the sensor block; (c) a first detector capable of detecting light from the light source which is internally reflected from the sensor surface; and (d) a second detector (e.g. a video camera) capable of detecting light scattered or emitted from an analyte bound thereto. Optionally the apparatus further comprises a second light source for increasing the intensity of the light scattered or emitted from an analyte bound to the sensor surface, preferably this is sited to such as to minimise the amount of light transmitted therefrom which is detected by the first detector. Also disclosed are sensors adapted for use in the apparatus, and methods of detecting analytes in samples comprising exposing samples to the sensor surface of the apparatus.
Patent PT-904351-E (PT)
Title: Animal cells and processes for the replication of influenza viruses
Inventor: GRONER ALBRECHT
IPC: C12N5/071
Filed: 1997-04-01
Abstract: Animal cells are described which can be infected by influenza viruses and which are adapted to growth in suspension in serum-free medium. Processes for the replication of influenza viruses in cell culture using these cells are furthermore described, as well as vaccines which contain the influenza viruses obtainable by the process or constituents thereof.
Patent PT-1025245-E (PT)
Inventor: TOMKINSON KATHLEEN
IPC: C12N15/85
Filed: 1998-10-21
Abstract: Disclosed are methods, DNA sequences, vectors and cell lines useful for the rapid generation of stable mammalian cell lines expressing high levels of recombinant proteins.
Patent PT-1137707-E (PT)
Inventor: JOHANSSON SOLVEIG
IPC: C08L23/04
Filed: 1999-09-24
Abstract: A multimodal polymer composition for pipes is disclosed as well as a pipes made thereof. The polymer is a multimodal polyethylene with a density of 0.930-0.965 g/cm3, and a viscosity at a shear stress of 747 Pa (eta747 Pa) of at least 650 Pa.s, said multimodal polyethylene comprising a low molecular weight (LMW) ethylene homopolymer fraction and a high molecular weight (HMW) ethylene copolymer fraction, said HMW fraction having a weight ratio of the LMW fraction to the HMW fraction of (35-55):(65-45). Preferably, the multimodal polyethylene has a viscosity at a shear stress of 2.7 kPa (eta2.7 kPa) of 260-450 kPa.s; and a shear thinning index (SHI) defined as the ratio of the viscosities at shear stresses of 2.7 and 210 kPa, respectively, of SHI27/210=50-150, and a storage modulus (G') at a loss modulus (G'') of 5 kPa, of G'5 kPa>=3000 Pa. The pipe is made of the multimodal polymer composition and withstands a stress of 8.0 MPa gauge during 50 years at 20° C. (MRS8.0). Preferably, the pipe has a rapid crack propagation (RCP) S4-value, determined according to ISO 13477:1997(E), of -5° C. or lower and a slow crack propagation resistance, determined according to ISO 13479:1997, of at least 500 hrs at 4.6 MPa/80° C. The polymer composition affords good non-sagging properties to pipe made thereof.
Patent IE-40679-L (IE)
Title: 1- [3- (naphth -1- yloxy) -2- propyl] piperazine¹derivatives.
IPC: C07D295/088
Filed: 1975-02-21
Abstract: New 1-[3-naphth-1-yloxy)-propyl]-piperazine compounds of the formula: <IMAGE> wherein X is hydrogen or methoxy; AND THE PHARMACOLOGICALLY COMPATIBLE SALTS THEREOF; ARE OUTSTANDINGLY EFFECTIVE IN LOWERING BLOOD PRESSURE AND ARE THUS USEFUL AS ANTI-HYPERTENSIVE AGENTS.
[US3997667A]
Patent IE-900400-L (IE)
Title: New benzazepines
IPC: C07D401/04
Filed: 1990-02-05
Abstract: Novel 2,3,4,5-tetrahydro-1H-3-benzazepines, which in the 7-position have a methoxymethyloxy group, in the 8-position hydrogen, halogen or a nitro group and in the 5-position have an optionally substituted phenyl ortho-fused ring-system, with interesting effects on the central nervous system.
Patent IE-780532-L (IE)
Title: Lipogenesis - inhibiting compositions
IPC: A61K31/335
Filed: 1978-03-15
Abstract: BIOLOGICALLY ACTIVE COMPOSITIONS AGAINST THE FORMATION OF LIPIDS AND CHOLESTEROL IN MAMMALS. 
THE ACTIVE COMPONENT IS A BICYCLIC COMPOUND FLAVOURED SUBSTITUTED WHEREIN ONE OF THE CORES IS A HETEROCYCLIC RING STRUCTURE HAS CONTAINING OXYGEN. 
MORE PARTICULARLY, THE ACTIVE COMPONENT IS A COMPOUND OF THE GENERAL FORMULA: (SEE PHOSETYL) WHEREIN X IS 
[FR2424741A1]
Patent IE-880560-L (IE)
Title: Enzyme immobilization and bioaffinity separations with¹perfluorocarbon polymer-based supports
IPC: C12N11/08
Filed: 1988-02-29
Abstract: A bioaffinity separation method is provided along with a solid affinity support utilized in that method. Additionally, immobilized enzyme systems are provided for use as enzyme electrode systems. The support is based on an inert carrier with ligands or binders attached to its surface. Methods for preparing such supports and their use in capturing target molecules from samples and in analytical applications are also provided.
[EP0281368A2]
Patent IE-39079-L (IE)
Title: Making cheese from skimmed milk
IPC: A23C9/142
Filed: 1974-03-19
Abstract: 1438533 Cheese DE DANSKE SUKKERFABRIKKER AS 19 March 1974 [20 March 1973] 13336/73 Heading A2B Skim milk is subjected to ultrafiltration to form a first concentrate, water or an aqueous salt solution is added to the first concentrate to dilute it, the diluted concentrate is subjected to a further ultafiltration to concentrate it, and this second concentrate is used in the manufacture of cheese. If desired, the second concentrate may be subjected to a third ultrafiltration. In one embodiment, the skim milk is passed along a path where ultrafiltration occurs continuously, the water or aqueous salt solution being added at some point along the path. Reference has been directed by the comptroller to Specification 1286403
[GB1438533A]
Patent IE-44730-L (IE)
Title: Phenyl piperazines
IPC: C07D405/06
Filed: 1977-03-30
Abstract: Phenylpiperazine derivatives of formula (I) <IMAGE> as well as their pharmaceutically acceptable salts, are prepared. R<1> represents benzyl, C1-6 alkyl or an optionally substituted phenyl; R<2> represents an optionally substituted phenyl, R<3> represents hydrogen or C1-4 alkyl, Q represents furan, thiophene, oxazole or thiazole, m is an integer from 1 to 3 and n is 0 or 1. When m is 2 and n is 0, R<1> cannot represent a methyl group when Q is the thiazol-5-yl group. The preparation is carried out by condensation of a compound of formula (VII): R<1>-Q-(CH2)m-(CHR<3>)n-L (VII) in which L represents the split group, with a compound of formula (VIII): <IMAGE> The compounds of formula (I) and their pharmaceutically acceptable salts are useful in the prophylactic and therapeutic treatment of diseases of immediate hypersensitiveness, especially asthma in mammals. They have a low toxicity.
[GB1575904A]
Patent IE-34426-L (IE)
Title: Fishing float assembly
IPC: A01K93/00
Filed: 1970-07-29
Abstract: The device of float type comprises a first element having in its upper part means for the attachment of the line, and in its lower part an external neck for winding thereon part of the line to be immersed extending beyond the point of attachment, a second element of a density adapted to ensure the buoyancy of the whole and movable relative to the first element between a bottom position in which the two elements confine a closed housing for the reception of the hook, the bait being attached to the hook and eventually separate fish food particles, and a top position in which the said housing is open to the exterior, the whole being such that on contact with the water, the second element is displaced relative to the first for opening the housing, releasing the hook bait and eventual particles and subsequent unwinding of the line from the neck.
[US3694951A]
Patent FI-814082-L (FI)
Inventor: ANDERSSON S INGMAR
IPC: E01C11/16
Filed: 1981-12-18
Abstract: A surfacing mass especially for outdoor use and mainly comprising a mixture of asphalt and a stone material having a low content of fine material. The mixture comprises a little amount of fibres of a type which is not solved or softens in the asphalt, preferably mineral fibres. The fibre material has an average diameter of between 1 and 5 mu m and is added in an amount of between 0,5 and 20% by weight calculated on the amount of asphalt. The invention also relates to a method of manufacturing such surfacing mass at a mixing temperature of 140-170 DEG C or preferably 150-160 DEG C both for the asphalt and the stone mass. Preferably the fibre material is admixed in the asphalt before the mixing thereof with the stone material. The fibre material may be admixed in the asphalt at an asphalt temperature which is higher than the mixing temperature for asphalt and stone material.
Patent IE-821083-L (IE)
Title: Cyanoacrylate adhesives
IPC: C09J4/04
Filed: 1982-05-06
Abstract: An adhesive composition comprises (a) at least one polymerizable cyanoacrylate monomer, (b) 0.1 to 10% by weight of a polymerizable acrylate ester e.g. allyl methacrylate and (c) 0.1 to 20% by weight of a maleimide derivative of formula <IMAGE> wherein R<7> and R<8> are from alkyl, cycloalkyl, aralkyl or arkaryl. The compositions may polymerize with ring-opening of the maleimide. They have excellent hot strength properties for long periods at 121 DEG C (250 DEG F) or more.
[GB2100273A]
Patent IE-801366-L (IE)
Title: Separation of gallium and rare earth oxides.
IPC: C01F17/276
Filed: 1980-06-30
Abstract: 1. Process for the treatment of a mixture of rare earth oxides and gallium oxides, characterized in that, in a first step, the mixture is dissolved by means of an acid, in a second step, the solution resulting from the acid attack is brought into contact with an organic phase containing at least one water-insoluble extraction agent, optionally dissolved in a diluent and chosen from amongst the class of the anionic extraction agents, the classes of the solvating extraction agents or the class of the cationic extraction agents, so as to seperate the gallium from the rare earths by liquid-liquid extraction, and in a third step, after the said extraction, the gallium is recovered in the organic phase and the rare earths in the aqueous phase, or the gallium is recovered in the aqueous phase and the rare earths in the organic phase.
Patent IE-801372-L (IE)
Title: Bleach composition.
IPC: C11D7/54
Filed: 1980-06-30
Abstract: Particulate bleach (and detergent) compositions with improved bleach efficiency are disclosed comprising a particulate peroxybleach compound and tetraacetyl ethylene diamine (TAED), said TAED having the following particle size distribution as determined by sieve analysis: 0-20%>150 mu m 10-100%>100 mu m<150 mu m 0-50%<75 mu m 0-20%<50 mu m, and being contained in granules in combination with a granulating agent, said granules having particle size ranging from 100-2000 mu m and comprising 10-99% by weight of TAED. The particulate bleach composition does not suffer from significant sedimentation and/or dissolution problems and does not suffer from significant decomposition problems during storage.
[US4283302A]
Patent IE-39604-L (IE)
Title: Benzofuran derivatives
IPC: A01N47/24
Filed: 1974-07-12
Abstract: A new class of chemical compounds useful for the control of insects consists of (methyl)(aminosulfenyl)carbamic acid esters of 2,3-dihydro-2,2-dimethyl-7-benzofuranol. The preparation of these compounds having a variety of (substituted-amino)sulfenyl groups, their physical properties, formulation, and use to control both household insects and crop pests are exemplified.
[US4006231A]
Patent IE-34247-L (IE)
Title: Aluminium phosphate fibres
IPC: C09D5/00
Filed: 1970-06-02
Abstract: Complex phosphates of aluminum containing a halogen and chemically-bound molecule of a hydroxy compound, which may be water or an organic hydroxy compound. A typical example is a complex phosphate containing ethyl alcohol having the empirical formula AlPClH25C8O8. They are most conveniently prepared by the reaction of an aluminum halide with the appropriate hydroxy compound and orthophosphoric acid, under relatively cool conditions. The compounds are generally soluble in water and polar organic solvents. They decompose at low temperatures to give aluminum orthophosphate, thereby providing a method for producing aluminum phosphate in many forms, for example, fibers, coatings, binders and fine particles, from a solution in water or organic solvents.
[US3870737A]
Patent IE-45843-L (IE)
Title: Continuous signal amplitude regulator
IPC: H04B3/10
Filed: 1977-11-22
Abstract: The present invention concerns the transmission of information, and consists in a continuous regulator responsive to the amplitude of a pilot tone included in the signal whose level is to be regulated, including a variable-gain quadripole through which said signal is passed, an automatic gain control loop including a circuit controlling the gain of the quadripole, and an auxiliary feedback loop through which the control circuit also controls the automatic gain control loop. The regulator is applicable with advantage to transmission systems.
[US4166981A]
Patent IE-43886-L (IE)
Title: Antifungal compositions
IPC: A61K9/00
Filed: 1976-11-29
Abstract: Antifungal compositions useful for the treatment of ringworm and other fungal infections comprising an antifungally effective amount of natamycin and a non-toxic, pharmaceutically acceptable organic acid compound and a suitable liquid carrier which compositions may be sprayed onto the animal, applied by a sponge or by other topical administration and concentrate comprising natamycin and the non-toxic, pharmaceutically acceptable organic acid compound in dry form.
[US4132777A]
Patent IE-893581-L (IE)
Title: Fuel briquettes and process for their preparation
IPC: C10L5/10
Filed: 1989-11-07
Abstract: Fuel briquets with a finely disperse carbon carrier of petroleum coke or of a mixture of mainly petroleum coke and coal (preferably non-caking coal) with a binder mixed with a finely disperse combustion inhibitor in the form of calcium carbonate and/or dolomite, which has been added in a quantity of more than 2% by weight to the starting mixture of the fuel briquet, volatile constituents having been expelled from the fuel briquet. A manufacturing process is also indicated.
Patent NO-803161-L (NO)
Title: Selvgaaende, automatisk transport- og drivanordning som forflytter seg paa en baerekabel
Inventor: CELLAI STELVIO
IPC: B61B7/06
Filed: 1980-10-23
Abstract: En automatisk selvbevegelig trekkmaskin for lufttransport langs en bærekabel omfatter hovedsakelig en original drivanordning som hindrer en hver sluring på bærekabelen (1) uansett helningen av kabelen, ved hjelp av en dynamisk selvlåsende, selvstabiliserende og selvregulert klemming proporsjonalt med lasten (29).Maskinen omfatter videre en anordning for automatisk kopling og fråkopling av motoren (24) en anordning. for automatisk bremsing ved enden av strekket så vel som en automatisk styreanordning for nedstignings-hastigheten i tilfelle av havari under sterk helning.Oppfinnelsen kan brukes for lufftrekk og lufttransport av ulik last (løft, håndtering, skogsdrift, ingeniør-arbeider) . For transport av personer (automobil eller "oppover-nedover" taubane) så vel som for strekking. av hjelpekabler ved strekking av kraftledninger.
Patent NO-810851-L (NO)
Title: Fremgangsmaate for fremstilling av aspartam (kunstig soetningsmiddel)
Inventor: BAHL CHANDER PRAKASH
IPC: C12R1/19
Filed: 1981-03-12
Abstract: Fremgangsmåte for fremstilling av :. det kunstige sotningsmiddel aspartam, som er et dipeptid med formel Asp-Phe-Me, 1 ved hjelp av en klonet mikroorganisme, '..' r. DNA som koder for et stort stabilt peptid bestående av den repeterende aminosyresekvens (Asp-Phe) ,innfores i en klonebefordrer som i sin tur innfores i en passende verts-mikroorganisme. Verts-mikroorganismen dyrkes og det store peptid inneholdende den gjentagende Asp-Phe-sekvens hostes derfra. Den fri karboksylgruppe av det store peptid benzyleres og hydrolyseres deretter til benzyl Asp-Phe-dipeptider. Dette dipeptid metyleres og debenzyleres deretter til å danne aspartam.
Patent NO-822793-L (NO)
Inventor: MIYADERA TETSUO
IPC: A61K31/40
Filed: 1982-08-17
Abstract: Compounds of the formula: <CHEM>  wherein: R<1> represents a hydrogen atom, a C2-3 alkyl group, a 1-hydroxyethyl group or a 1-hydroxy-1-methylethyl group;  R<2> represents a group of formula: <CHEM> in which, X represents a hydrogen atom, an alkyl group, a cyanoalkyl group, a haloalkyl group, an alkoxyalkyl group, an alkylthioalkyl group, an alkoxycarbonylalkyl group, an alkoxy group, an alkylthio group, an alkylsulphinyl group, an alkylsulphonyl group, a hydroxy group or a halogen atom, where each alkyl or alkoxy has 1-4 carbon atoms; Y represents a hydrogen atom, a C1-4 alkyl group, a C1-4 alkyl group substituted by a hydroxy, amino, carboxy or C1-4 alkoxy group, a C1-5 aliphatic acyl group, a C1-5 aliphatic acyl group substituted by a hydroxy, amino, carboxy or C1-4 alkoxy group, a group of formula -C(R<5>)=N-R<6> (R<5> and R<6> each represents a hydrogen or C1-4 alkyl). <CHEM> represents a 2- or 3-azetidinyl, a 2- or 3-pyrrolidinyl, a 2-, 3- or 4-piperidyl or a 3,4,5,6-tetrahydropyrimidin-5-yl. R<3> represents a carboxy group or a protected carboxy group, and pharmaceutically acceptable salts thereof, provided that when the group <CHEM>  is a 4-piperidyl group then Y is not a C1-4 alkyl group and when <CHEM> is a 3-pyrrolidinyl group Y is not a group then Y is not a group -C(R<5>)=n-R<6>, are useful antibiotics.
Patent NO-830578-L (NO)
Inventor: MATHER FRANK WATKINS III
IPC: B01D63/02
Filed: 1983-02-18
Abstract: A hollow fibre oxygenator, assembly containing same, and method for making same wherein a hollow fibre oxygenator element (60) utilizes gas permeable hollow fibres (62) to transfer oxygen into and carbon dioxide from blood flowing around the outside of the fibres (62) while oxygen flows througn the fibre lumens. The hollow fibres (62) are arranged in tapes (70) wound helically in layers around a hollow cylindrical core (40). The fibres (62) in each tape (70) angularly cross the fibres (62) in the radially adjacent tape (70), are spaced axially from each other, and are substantially equally spaced radially from the periphery of the core (40) such that the crossing fibres (62) in the radially adjacent layers (70) form small interconnected gaps that permit thin-film radial blood flow with a low blood phase pressure drop and efficient gas transfer. The oxygenator element (60) is sealed into a shell (12) to form spaced apart oxygen header chamber (48,53) at opposite ends of the core (40) that are sealed from an annular blood chamber (18) surrounding the oxygenator element (60). The shell (12) is provided with inlet and outlet ports (64) for supplying oxygen to one header chamber, through the hollow fibre lumens, and out of the opposite chamber while blood supplied to the core (40) permeates radially outwardly around the hollow fibres (62) and through the layers (70) to the surrounding annular blood chamber (18) as purified and oxygenated blood. The oxygenator (60) is integrated into a single unit assembly having a top blood reservoir (24) attached to a blood heater (26) that is attached to the blood oxygenator (60) in vertical array.